We know that these drugs not only lead to weight loss, but also provide some protection against diabetes, heart, kidney and liver disease
[2] - [5] Recent phase 2 clinical trial data evaluating the activity and safety of GLP-3 in subjects with type 2 diabetes demonstrate its pronounced effects on both glycemic control and body weight reduction
With its potential to transform lives, it presents a compelling option for many
Social, clinical, and policy implications of ultra-processed food addiction
Completion rates are high, with 81% of members finishing the first year and 70% enrolling in a second year, suggesting strong engagement and program adherence
Step 2 pick your weekly dose